Welcome to AD/PD™ on UNLOK!
The eLearning Portal of the AD/PD™ Conference, full of online courses, webinars, Conference videos, research papers, and so much more!
This platform is your gateway to a treasure trove of valuable information and resources, meticulously curated to empower Health Care Professionals specializing in neurodegenerative diseases.
Engage, Share, and Collaborate
Are you interested in sharing your latest research findings or case studies with an attentive audience of colleagues? Would you like to lead a discussion or give an analysis of an interesting new or controversial topic? This is your chance!
OUR EDUCATION OFFERINGS
Continuous learning is key. Immerse yourself in our self-paced learning courses, designed to enhance your knowledge and amplify patient outcomes. Each module brings you one step closer to honing your expertise.
α-syn pathology in the periphery: A window into early diagnosis
This session convened distinguished scholars Prof. Per Borghammer, Prof. Beomseok Jeon, Prof. Tiago Outeiro, and Prof. Erwan Bezard to delve into the intricacies and challenges surrounding the diagnosis and understanding of Parkinson's Disease (PD).
Evaluating Donanemab's Efficacy and its Role in Alzheimer's Disease Treatment
This session brought together esteemed experts Curtis P. Schrieber, MD, Giacomo Koch, MD, PhD and Miranda E. Orr, PhD to explore the implications of these findings for future research and the potential impact on patient outcomes.
Meet the Expert interviews
At AD/PD™ 2023, we connected with leading experts like Dr. Marc Diamond, Prof. Li-Huei Tsai, and Dr. Melissa Murray. These discussions offered valuable insights into their careers and the future of Alzheimer's and Parkinson's diseases' researchers.
Entering the Era of Disease-Modifying Treatments for AD
This symposium discussed how the efficacy of anti-amyloid beta (Aβ) monoclonal antibodies (mAbs) was evaluated in clinical trials (both for therapeutic and preventive treatment of Alzheimer’s disease) versus in real-world clinical practice and explored how clinically meaningful outcomes for patients living with AD may be defined in today’s clinical practice.
Detecting Brain Amyloid Burden with PET
GE Healthcare brings its 4 module e-learning certification course on detecting brain amyloid burden with PET. In this module, learn about the evolution of MCI and AD diagnosis and the role of biomarkers. This course is open to healthcare professionals who are based in Europe.
UPCOMING EVENTS
Witness medical advancements as we gather doctors and researchers from across the globe. Our live events and interactive webinars offer a front-row seat to the latest breakthroughs shaping the future of neurodegenerative diseases cure and management.
AD/PD™2024 Conference
Join us for the International Conference on Alzheimer's and Parkinson's Diseases and related neurological disorders, on March 5-9 2024, in Lisbon, Portugal.
Diagnosis and biomarkers in Alzheimer’s disease: current scenario and future perspectives
This webinar will explore the intricate landscape of Alzheimer’s disease diagnosis and biomarkers, including, an examination of qualitative and quantitative diagnosis methods, an exploration of the challenges obstructing early detection, and a discussion of the imperative for non-invasive and cost-effective biomarkers.
The AD/PD™23 Conference Recordings are now live!
Did you miss the AD/PD™23 Conference last year? You can now view more than 100 hours of content in the AD/PD™ Education Portal!